In the survey, conducted online by Harris Interactive on behalf of Talecris, neurologists selected Gamunex over four times more often than all other available liquid IGIV therapies, with a statistically significant margin (p<0.05).
LOL re the p-value.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”